Rising Biosciences, Inc. Announces Shareholder Conference Call, Wednesday, August 26th

SANDUSKY, OH / ACCESSWIRE / August 20, 2020 / Rising Biosciences, Inc. (OTC PINK:RBII) CEO Arthur Hall is extending an invitation to a shareholder conference call at 4:30 PM EDT on Wednesday, August 26th.

“Shareholders and people following RBII are invited to participate”, said Hall. “We have experienced solid growth in 2020 and we’re excited to answer questions, share our enthusiasm and discuss what the coming months will bring. We’ll have several of our master distributors on the call, so participants can gain valuable perspective from them, first-hand.”

Hall also said he was proud of the way RBII has performed in the face of unprecedented times. “We’ve been able to react positively”, he added. “As stated previously, we had record revenues in Q2 and our supply chain is uninterrupted. We’ll also touch on our expansion and our national contracts. We have a lot of good things to discuss on this conference call.”

To participate on the call, dial (805) 706-4830 and enter code GORBII (467244).

About Rising Biosciences, Inc.

About Rising Biosciences Inc. – In addition to Oxi Thyme, RBII operates three distinct business units. The first business unit is a physicians practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The second business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA. The third business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest.

Follow $RBII on the NEW Twitter account and on Facebook for LIVE updates!



Cautionary Statement Regarding Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

CONTACT INFO: For Investor Inquiries: IR@risingbiosciences.com

SOURCE: Rising Biosciences, Inc.

View source version on accesswire.com:

error: Content is protected !!